sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide

C156H203BBr6N30NaO29P — CID 157070278

About sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide

sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide (PubChem CID 157070278) has the molecular formula C156H203BBr6N30NaO29P and a molecular weight of 3512.75 g/mol. Its IUPAC name is sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide.

Molecular Properties

• Compound Name: sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide
• PubChem CID: 157070278
• Molecular Formula: C156H203BBr6N30NaO29P
• Molecular Weight: 3512.75 g/mol
• Exact Mass: 3505.04
• IUPAC Name: sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide
• SMILES: CC(C)(C)OC(=O)NCCCCO.CC=Nc1cccc(C(=O)C/N=C/N(C)C)n1.CCN(CC)CC.CN1CC=C(B2OC(C)(C)C(C)(C)O2)CC1.CN1CC=C(c2ccc3c(c2)OCCCCn2cnnc2-c2cccc(n2)NC3=O)CC1.COC(=O)c1ccc(Br)cc1O.COC(=O)c1ccc(Br)cc1OCCCCN.COC(=O)c1ccc(Br)cc1OCCCCNC(=O)OC(C)(C)C.COC(=O)c1ccc(Br)cc1OCCCCn1cnnc1-c1cccc(NC=O)n1.Nc1cccc(-c2nncn2CCCCOc2cc(Br)ccc2C(=O)O)n1.O=C1Nc2cccc(n2)-c2nncn2CCCCOc2cc(Br)ccc21.[3H]P([3H])[3H].[Na+].[OH-]
• InChI: InChI=1S/C24H26N6O2.C20H20BrN5O4.C18H18BrN5O3.C18H16BrN5O2.C17H24BrNO5.C12H22BNO2.C12H16BrNO3.C12H16N4O.C9H19NO3.C8H7BrO3.C6H15N.Na.H2O.H3P/c1-29-12-9-17(10-13-29)18-7-8-19-21(15-18)32-14-3-2-11-30-16-25-28-23(30)20-5-4-6-22(26-20)27-24(19)31;1-29-20(28)15-8-7-14(21)11-17(15)30-10-3-2-9-26-12-23-25-19(26)16-5-4-6-18(24-16)22-13-27;19-12-6-7-13(18(25)26)15(10-12)27-9-2-1-8-24-11-21-23-17(24)14-4-3-5-16(20)22-14;19-12-6-7-13-15(10-12)26-9-2-1-8-24-11-20-23-17(24)14-4-3-5-16(21-14)22-18(13)25;1-17(2,3)24-16(21)19-9-5-6-10-23-14-11-12(18)7-8-13(14)15(20)22-4;1-11(2)12(3,4)16-13(15-11)10-6-8-14(5)9-7-10;1-16-12(15)10-5-4-9(13)8-11(10)17-7-3-2-6-14;1-4-14-12-7-5-6-10(15-12)11(17)8-13-9-16(2)3;1-9(2,3)13-8(12)10-6-4-5-7-11;1-12-8(11)6-3-2-5(9)4-7(6)10;1-4-7(5-2)6-3;;;/h4-9,15-16H,2-3,10-14H2,1H3,(H,26,27,31);4-8,11-13H,2-3,9-10H2,1H3,(H,22,24,27);3-7,10-11H,1-2,8-9H2,(H2,20,22)(H,25,26);3-7,10-11H,1-2,8-9H2,(H,21,22,25);7-8,11H,5-6,9-10H2,1-4H3,(H,19,21);6H,7-9H2,1-5H3;4-5,8H,2-3,6-7,14H2,1H3;4-7,9H,8H2,1-3H3;11H,4-7H2,1-3H3,(H,10,12);2-4,10H,1H3;4-6H2,1-3H3;;1H2;1H3/q;;;;;;;;;;;+1;;/p-1/b;;;;;;;13-9+,14-4?;;;;;;/i;;;;;;;;;;;;;1T3
• InChIKey: ACIPCWNUDHMULG-CWSPOCHRSA-M
• XLogP: 24.76
• TPSA: 744.84 Ų
• H-Bond Donors: 10
• H-Bond Acceptors: 52
• Rotatable Bonds: 46
• Heavy Atoms: 224
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3512.75
LogP ≤ 5	24.76
H-Bond Donors ≤ 5	10
H-Bond Acceptors ≤ 10	52

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide?

The IUPAC name of sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide (CID 157070278) is sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide.

What is the SMILES notation for sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide?

The canonical SMILES for sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide is CC(C)(C)OC(=O)NCCCCO.CC=Nc1cccc(C(=O)C/N=C/N(C)C)n1.CCN(CC)CC.CN1CC=C(B2OC(C)(C)C(C)(C)O2)CC1.CN1CC=C(c2ccc3c(c2)OCCCCn2cnnc2-c2cccc(n2)NC3=O)CC1.COC(=O)c1ccc(Br)cc1O.COC(=O)c1ccc(Br)cc1OCCCCN.COC(=O)c1ccc(Br)cc1OCCCCNC(=O)OC(C)(C)C.COC(=O)c1ccc(Br)cc1OCCCCn1cnnc1-c1cccc(NC=O)n1.Nc1cccc(-c2nncn2CCCCOc2cc(Br)ccc2C(=O)O)n1.O=C1Nc2cccc(n2)-c2nncn2CCCCOc2cc(Br)ccc21.[3H]P([3H])[3H].[Na+].[OH-].

What is the InChIKey of sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide?

The InChIKey is ACIPCWNUDHMULG-CWSPOCHRSA-M. The full InChI is InChI=1S/C24H26N6O2.C20H20BrN5O4.C18H18BrN5O3.C18H16BrN5O2.C17H24BrNO5.C12H22BNO2.C12H16BrNO3.C12H16N4O.C9H19NO3.C8H7BrO3.C6H15N.Na.H2O.H3P/c1-29-12-9-17(10-13-29)18-7-8-19-21(15-18)32-14-3-2-11-30-16-25-28-23(30)20-5-4-6-22(26-20)27-24(19)31;1-29-20(28)15-8-7-14(21)11-17(15)30-10-3-2-9-26-12-23-25-19(26)16-5-4-6-18(24-16)22-13-27;19-12-6-7-13(18(25)26)15(10-12)27-9-2-1-8-24-11-21-23-17(24)14-4-3-5-16(20)22-14;19-12-6-7-13-15(10-12)26-9-2-1-8-24-11-20-23-17(24)14-4-3-5-16(21-14)22-18(13)25;1-17(2,3)24-16(21)19-9-5-6-10-23-14-11-12(18)7-8-13(14)15(20)22-4;1-11(2)12(3,4)16-13(15-11)10-6-8-14(5)9-7-10;1-16-12(15)10-5-4-9(13)8-11(10)17-7-3-2-6-14;1-4-14-12-7-5-6-10(15-12)11(17)8-13-9-16(2)3;1-9(2,3)13-8(12)10-6-4-5-7-11;1-12-8(11)6-3-2-5(9)4-7(6)10;1-4-7(5-2)6-3;;;/h4-9,15-16H,2-3,10-14H2,1H3,(H,26,27,31);4-8,11-13H,2-3,9-10H2,1H3,(H,22,24,27);3-7,10-11H,1-2,8-9H2,(H2,20,22)(H,25,26);3-7,10-11H,1-2,8-9H2,(H,21,22,25);7-8,11H,5-6,9-10H2,1-4H3,(H,19,21);6H,7-9H2,1-5H3;4-5,8H,2-3,6-7,14H2,1H3;4-7,9H,8H2,1-3H3;11H,4-7H2,1-3H3,(H,10,12);2-4,10H,1H3;4-6H2,1-3H3;;1H2;1H3/q;;;;;;;;;;;+1;;/p-1/b;;;;;;;13-9+,14-4?;;;;;;/i;;;;;;;;;;;;;1T3.

What are the key properties of sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide?

sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide has a molecular weight of 3512.75 g/mol, XLogP of 24.76, 46 rotatable bonds, 10 hydrogen bond donors, and 52 hydrogen bond acceptors.

Where does this data come from?

All data for sodium;2-[4-[3-(6-amino-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]-4-bromobenzoic acid;14-bromo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;tert-butyl N-(4-hydroxybutyl)carbamate;N,N-diethylethanamine;N'-[2-[6-(ethylideneamino)-2-pyridinyl]-2-oxoethyl]-N,N-dimethylmethanimidamide;methyl 2-(4-aminobutoxy)-4-bromobenzoate;methyl 4-bromo-2-[4-[3-(6-formamido-2-pyridinyl)-1,2,4-triazol-4-yl]butoxy]benzoate;methyl 4-bromo-2-hydroxybenzoate;methyl 4-bromo-2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]butoxy]benzoate;14-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine;tritritiophosphane;hydroxide is sourced from PubChem (CID 157070278), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).